期刊文献+

参芪扶正注射液对小鼠肝转移癌组织基因表达谱的影响 被引量:22

Effects of Shenqi Fuzheng Injection on Gene Expression Profile of Liver Tissue with Metastatic Carcinoma in Mice
下载PDF
导出
摘要 目的探讨参芪扶正注射液对小鼠肝转移癌组织基因表达谱的影响。方法20只小鼠采用将结肠癌C26细胞株瘤细胞液0.2mL注射于脾脏建立肝转移癌模型,随机分为两组,造模后5日,分别给予参芪扶正注射液(参芪组)和生理盐水(模型组)腹腔内注射,隔日1次,共5次;造模后15日处死动物留取检测标本,应用小鼠全基因芯片分析两组肝癌组织基因表达谱。结果(1)造模成功率100%;(2)基因表达:与模型组比较,参芪组上调基因123个,其中Ensemble数据库登录52个;下调基因1个,其中Ensemble数据库登录0个。结论参芪扶正注射液主要是通过上调多种基因促进肿瘤细胞凋亡和稳定染色体而发挥抗肿瘤作用。 Objective To explore the effect of Shenqi Fuzheng Injection (SFI) on gene expression profile of liver tissue with metastatic carcinoma in mice. Methods Twenty liver metastatic carcinoma model mice were established by splenectomy after their spleens were injected with 0.2 mL colon cancer C26 cell strain oncocyte liquid, then they were randomly divided into the model group and the SFI group. Starting from the 5th day after modeling, mice in the model group and the SFI group were given via intraperitoneal injection once every other day with physiological saline and SFI respectively. All the mice were sacrificed at the 15th day and the gene profile of metastatic liver carcinoma tissue in the two groups were screened by whole genome chip technique. Results (1) The model establishing successful rate reached 100% ; (2) Gene expression showed that as compared with the model group, in the SFI group, 123 genes were up-regulated, with 52 of them registered to down-regulated and registered to Ensemble was none. Conclusion SFI plays Ensemble, while only one gene was its role of anti-tumor mainly by upregulating several relative genes to promote apoptosis of tumor ceils and stabilizing chromosomes.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2008年第2期135-138,共4页 Chinese Journal of Integrated Traditional and Western Medicine
基金 教育部产学研综合项目基金资助(No.2006D90504018)
关键词 参芪扶正注射液 基因表达谱 肝转移癌 Shenqi Fuzheng Injection gene expression profile liver metastatic cancer
  • 相关文献

参考文献18

  • 1钟陆行,熊建萍,张锡泉.参芪扶正注射液对K562/ADM多药耐药的影响[J].江西医学院学报,2006,46(4):41-44. 被引量:7
  • 2Johnstone RW, Ruefli AA, Lowe SW. Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002 ; 108 (2) : 153--164.
  • 3Cory S, Adams JM. The bcl-2 family : regulators of the cellular life-or-death switch. Nat Rev Cancer 2002:2(9) : 647-656.
  • 4Cheah PL,Looi LM. p53 : an overview of over two decades of study. Malays J Pathol 2001 ;23 ( 1 ): 9-16.
  • 5Wang W, Rastinejad F, E1-Deiry WS. Restoring p53-dependent tumor suppression. Cancer Biol Ther 2003; 2 (4 Suppl 1 ): 55-63.
  • 6Haupt S, Haupt Y. Importance of p53 for cancer onset and therapy. Anticancer Drugs 2006 ; 17 ( 7 ) : 725-732.
  • 7Rich T, Allen RL, Wyllie AH. Defying death after DNA damage. Nature 2000 ;407 ( 6805 ) : 777-783.
  • 8Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002 ; 2 ( 8 ) : 594-604.
  • 9Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001 ;7(3):683-694.
  • 10Yu J, Zhang L, Hwang PM, et al. PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 2001 ; 7 (3) : 673-682.

二级参考文献10

共引文献6

同被引文献229

引证文献22

二级引证文献136

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部